Comprehensive bioinformatics analysis reveals the hub genes and pathways associated with multiple myeloma

References

• Roy P, Sarkar UA, Basak S. The NF-κB Activating Pathways in Multiple Myeloma. Biomedicines. 2018;6(2):59, doi: 10.3390/biomedicines6020059.
   PubMed Web of Science ®Google Scholar
• Cowan AJ, Allen C, Barac A, et al. Global Burden of Multiple Myeloma: A Systematic Analysis for the Global Burden of Disease Study 2016. JAMA Oncol. 2018;4(9):1221–1227. doi: 10.1001/jamaoncol.2018.2128.
   PubMed Web of Science ®Google Scholar
• Zhou L, Yu Q, Wei G, et al. Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019. BMC Cancer. 2021;21(1):606, doi: 10.1186/s12885-021-08280-y.
   PubMed Web of Science ®Google Scholar
• Burks JD, Elarjani T, Jamshidi AM, et al. Vertebral multiple myeloma with pathological fracture: the most common etiology for emergency spine surgery in patients with no cancer diagnosis on admission. Neurosurg Focus. 2021;50(5):E2, doi: 10.3171/2021.2.FOCUS201038.
   PubMed Web of Science ®Google Scholar
• Giannakoulas N, Ntanasis-Stathopoulos I, Terpos E. The Role of Marrow Microenvironment in the Growth and Development of Malignant Plasma Cells in Multiple Myeloma. Int J Mol Sci. 2021;22(9):4462, doi: 10.3390/ijms22094462.
   PubMed Web of Science ®Google Scholar
• Samur MK, Fulciniti M, Aktas Samur A, et al. Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma. Nat Commun. 2021;12(1):868, doi: 10.1038/s41467-021-21177-5.
   PubMed Web of Science ®Google Scholar
• Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538–e548. doi: 10.1016/S1470-2045(14)70442-5.
   PubMed Web of Science ®Google Scholar
• Ho M, Patel A, Goh CY, et al. Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM). Leukemia. 2020;34(12):3111–3125. doi: 10.1038/s41375-020-01051-x.
   PubMed Web of Science ®Google Scholar
• Pawlyn C, Davies FE. Toward personalized treatment in multiple myeloma based on molecular characteristics. Blood. 2019;133(7):660–675. doi: 10.1182/blood-2018-09-825331.
   PubMed Web of Science ®Google Scholar
• Jia NY, Liu XZ, Zhang Z, et al. Weighted Gene Co-expression Network Analysis Reveals Different Immunity but Shared Renal Pathology Between IgA Nephropathy and Lupus Nephritis. Front Genet. 2021;12(634171). doi: 10.3389/fgene.2021.634171.
   Google Scholar
• Yang J, Wang F, Chen B. HLA-DPA1 gene is a potential predictor with prognostic values in multiple myeloma. BMC Cancer. 2020;20(1):915, doi: 10.1186/s12885-020-07393-0.
   PubMed Web of Science ®Google Scholar
• Peng Y, Wu D, Li F, et al. Identification of key biomarkers associated with cell adhesion in multiple myeloma by integrated bioinformatics analysis. Cancer Cell Int. 2020;20(262). doi: 10.1186/s12935-020-01355-z.
   Google Scholar
• Choudhury SR, Ashby C, Tytarenko R, et al. The functional epigenetic landscape of aberrant gene expression in molecular subgroups of newly diagnosed multiple myeloma. J Hematol Oncol. 2020;13(1):108, doi: 10.1186/s13045-020-00933-y.
   PubMed Web of Science ®Google Scholar
• Carroll HD, Kann MG, Sheetlin SL, et al. Threshold Average Precision (TAP-k): a measure of retrieval designed for bioinformatics. Bioinformatics. 2010;26(14):1708–1713. doi: 10.1093/bioinformatics/btq270.
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47, doi: 10.1093/nar/gkv007.
   PubMed Web of Science ®Google Scholar
• Ito K, Murphy D. Application of ggplot2 to Pharmacometric graphics. CPT Pharmacometrics Syst Pharmacol. 2013;2(10):e79), doi: 10.1038/psp.2013.56.
   PubMedGoogle Scholar
• Dennis G, Sherman BT, Hosack DA, et al. David: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003;4(5):P3. doi: 10.1186/gb-2003-4-5-p3.
   PubMed Web of Science ®Google Scholar
• van Gastel J, Hendrickx JO, Leysen H, et al. β-Arrestin Based Receptor Signaling Paradigms: Potential Therapeutic Targets for Complex Age-Related Disorders. Front Pharmacol. 2018;9:1369. doi: 10.3389/fphar.2018.01369.
   PubMed Web of Science ®Google Scholar
• Li X, Liu Z, Mi M, et al. Identification of hub genes and key pathways associated with angioimmunoblastic T-cell lymphoma using weighted gene co-expression network analysis. Cancer Manag Res. 2019;11:5209–5220. doi: 10.2147/CMAR.S185030.
   PubMed Web of Science ®Google Scholar
• Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9(559). doi: 10.1186/1471-2105-9-559.
   PubMedGoogle Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504. doi: 10.1101/gr.1239303.
   PubMed Web of Science ®Google Scholar
• Grau J, Grosse I, Keilwagen J. PRROC: computing and visualizing precision-recall and receiver operating characteristic curves in R. Bioinformatics. 2015;31(15):2595–2597. doi:10.1093/bioinformatics/btv153.
   PubMed Web of Science ®Google Scholar
• Subramanian A, Kuehn H, Gould J, et al. GSEA-P: a desktop application for gene set enrichment analysis. Bioinformatics. 2007;23(23):3251–3253. doi:10.1093/bioinformatics/btm369.
   PubMed Web of Science ®Google Scholar
• Garcia-Gomez A, Li T, de la Calle-Fabregat C, et al. Targeting aberrant DNA methylation in mesenchymal stromal cells as a treatment for myeloma bone disease. Nat Commun. 2021;12(1):421), doi: 10.1038/s41467-020-20715-x.
   PubMed Web of Science ®Google Scholar
• Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011;364(11):1046–1060. doi: 10.1056/NEJMra1011442.
   PubMed Web of Science ®Google Scholar
• Liu X, Xiao W, Zhang Y, et al. Reversible phosphorylation of Rpn1 regulates 26S proteasome assembly and function. Proc Natl Acad Sci USA. 2020;117(1):328–336. doi: 10.1073/pnas.1912531117.
   PubMed Web of Science ®Google Scholar
• Chojnacki M, Mansour W, Hameed DS, et al. Polyubiquitin-Photoactivatable Crosslinking Reagents for Mapping Ubiquitin Interactome Identify Rpn1 as a Proteasome Ubiquitin-Associating Subunit. Cell Chem Biol. 2017;24(4):443–457. doi: 10.1016/j.chembiol.2017.02.013.
   PubMed Web of Science ®Google Scholar
• Shi Y, Chen X, Elsasser S, et al. Rpn1 provides adjacent receptor sites for substrate binding and deubiquitination by the proteasome. Science. 2016;351(6275) 10.1126/science.aad9421 aad9421. doi: 10.1126/science.aad9421.
   Web of Science ®Google Scholar
• Boughton AJ, Krueger S, Fushman D. Branching via K11 and K48 Bestows Ubiquitin Chains with a Unique Interdomain Interface and Enhanced Affinity for Proteasomal Subunit Rpn1. Structure. 2020;28(1):29–43. doi: 10.1016/j.str.2019.10.008.
   PubMed Web of Science ®Google Scholar
• Liang JR, Lingeman E, Luong T, et al. A Genome-wide ER-phagy Screen Highlights Key Roles of Mitochondrial Metabolism and ER-Resident UFMylation. Cell. 2020;180(6):1160–1177. doi: 10.1016/j.cell.2020.02.017.
   PubMed Web of Science ®Google Scholar
• Zheng Z, Wang L, Cheng S, et al. Autophagy and Myeloma. Adv Exp Med Biol. 2020;1207:625–631. doi: 10.1007/978-981-15-4272-5_45.
   PubMed Web of Science ®Google Scholar
• Van den Berg B, Clemons WM Jr, Collinson I, et al. X-ray structure of a protein-conducting channel. Nature. 2004;427(6969):36–44. doi: 10.1038/nature02218.
   PubMed Web of Science ®Google Scholar
• Bolar NA, Golzio C, Živná M, et al. Heterozygous Loss-of-Function SEC61A1 Mutations Cause Autosomal-Dominant Tubulo-Interstitial and Glomerulocystic Kidney Disease with Anemia. Am J Hum Genet. 2016;99(1):174–187. doi: 10.1016/j.ajhg.2016.05.028.
   PubMed Web of Science ®Google Scholar
• Devuyst O, Olinger E, Weber S, et al. Autosomal dominant tubulointerstitial kidney disease. Nat Rev Dis Primers. 2019;5(1):60, doi: 10.1038/s41572-019-0109-9.
   PubMed Web of Science ®Google Scholar
• Fa X, Song P, Fu Y, et al. Long non-coding RNA VPS9D1-AS1 facilitates cell proliferation, migration and stemness in hepatocellular carcinoma. Cancer Cell Int. 2021;21(1):131, doi: 10.1186/s12935-020-01741-7.
   PubMed Web of Science ®Google Scholar
• Todd DJ, McHeyzer-Williams LJ, Kowal C, et al. XBP1 governs late events in plasma cell differentiation and is not required for antigen-specific memory B cell development. J Exp Med. 2009;206(10):2151–2159. doi: 10.1084/jem.20090738.
   PubMed Web of Science ®Google Scholar
• Schubert D, Klein MC, Hassdenteufel S, et al. Plasma cell deficiency in human subjects with heterozygous mutations in Sec61 translocon alpha 1 subunit (SEC61A1). J Allergy Clin Immunol. 2018;141(4):1427–1438. doi: 10.1016/j.jaci.2017.06.042.
   PubMed Web of Science ®Google Scholar
• Kalies KU, Hartmann E. Membrane topology of the 12- and the 25-kDa subunits of the mammalian signal peptidase complex. J Biol Chem. 1996;271(7):3925–3929. doi: 10.1074/jbc.271.7.3925.
   PubMed Web of Science ®Google Scholar
• Banerjee A, Tripathi A. Recent advances in understanding Japanese encephalitis. F1000Res. 2019;8 F1000 Faculty Rev-1915. doi: 10.12688/f1000research.19693.1.
   PubMedGoogle Scholar
• Mohd Ropidi MI, Khazali AS, Nor Rashid N, et al. Endoplasmic reticulum: a focal point of Zika virus infection. J Biomed Sci. 2020;27(1):27, doi: 10.1186/s12929-020-0618-6.
   PubMed Web of Science ®Google Scholar
• Schwartz T, Blobel G. Structural basis for the function of the beta subunit of the eukaryotic signal recognition particle receptor. Cell. 2003;112(6):793–803. doi: 10.1016/s0092-8674(03)00161-2.
   PubMed Web of Science ®Google Scholar
• Rowley JD, Diaz MO, Espinosa R 3rd, et al. Mapping chromosome band 11q23 in human acute leukemia with biotinylated probes: identification of 11q23 translocation breakpoints with a yeast artificial chromosome. Proc Natl Acad Sci USA. 1990;87(23):9358–9362. doi: 10.1073/pnas.87.23.9358.
   PubMed Web of Science ®Google Scholar
• Crossen PE, Morrison MJ, Rodley P, et al. Identification of amplified genes in a patient with acute myeloid leukemia and double minute chromosomes. Cancer Genet Cytogenet. 1999;113(2):126–133. doi: 10.1016/s0165-4608(99)00018-7.
   PubMedGoogle Scholar
• Ma Q, Wu X, Wu J, et al. SERP1 is a novel marker of poor prognosis in pancreatic ductal adenocarcinoma patients via anti-apoptosis and regulating SRPRB/NF-κB axis. Int J Oncol. 2017;51(4):1104–1114. doi: 10.3892/ijo.2017.4111.
   PubMed Web of Science ®Google Scholar
• Kim BK, Yoo HI, Choi K, et al. Regulation of Srpr Expression by miR-330-5p Controls Proliferation of Mouse Epidermal Keratinocyte. PLoS One. 2016;11(10):e0164896. doi: 10.1371/journal.pone.0164896.
   PubMed Web of Science ®Google Scholar
• Markovina S, Callander NS, O'Connor SL, et al. Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-kappaB activity in myeloma cells. Mol Cancer. 2010;9(176). doi: 10.1186/1476-4598-9-176.
   PubMedGoogle Scholar
• Vogel F, Hartmann E, Görlich D, et al. Segregation of the signal sequence receptor protein in the rough endoplasmic reticulum membrane. Eur J Cell Biol. 1990;53(2):197–202.
   PubMed Web of Science ®Google Scholar
• Kajimoto K, Minami Y, Harashima H. Cytoprotective role of the fatty acid binding protein 4 against oxidative and endoplasmic reticulum stress in 3T3-L1 adipocytes. FEBS Open Bio. 2014;4:602–610. doi: 10.1016/j.fob.2014.06.008.
   PubMed Web of Science ®Google Scholar
• Huang Y, Xu X, Arvan P, et al. Deficient endoplasmic reticulum translocon-associated protein complex limits the biosynthesis of proinsulin and insulin. FASEB J. 2021;35(5):e21515, doi: 10.1096/fj.202002774R.
   PubMed Web of Science ®Google Scholar
• Yan J, Wang ZH, Yan Y, et al. RP11-156L14.1 regulates SSR1 expression by competitively binding to miR-548ao-3p in hypopharyngeal squamous cell carcinoma. Oncol Rep. 2020;44(5):2080–2092. doi: 10.3892/or.2020.7762.
   PubMed Web of Science ®Google Scholar
• Ng BG, Lourenço CM, Losfeld ME, et al. Mutations in the translocon-associated protein complex subunit SSR3 cause a novel congenital disorder of glycosylation. J Inherit Metab Dis. 2019;42(5):993–997. doi: 10.1002/jimd.12091.
   PubMed Web of Science ®Google Scholar
• Rapoport TA, Goder V, Heinrich SU, et al. Membrane-protein integration and the role of the translocation channel. Trends Cell Biol. 2004;14(10):568–575. doi: 10.1016/j.tcb.2004.09.002.
   PubMed Web of Science ®Google Scholar
• Klein MC, Lerner M, Nguyen D, et al. TRAM1 protein may support ER protein import by modulating the phospholipid bilayer near the lateral gate of the Sec61-channel. Channels (Austin). 2020;14(1):28–44. doi: 10.1080/19336950.2020.1724759.
   PubMed Web of Science ®Google Scholar
• Ng CL, Oresic K, Tortorella D. TRAM1 is involved in disposal of ER membrane degradation substrates. Exp Cell Res. 2010;316(13):2113–2122. doi: 10.1016/j.yexcr.2010.04.010.
   PubMed Web of Science ®Google Scholar
• Akhtar S, Ali TA, Faiyaz A, et al. Cytokine-Mediated Dysregulation of Signaling Pathways in the Pathogenesis of Multiple Myeloma. Int J Mol Sci. 2020;21(14):5002, doi: 10.3390/ijms21145002.
   PubMed Web of Science ®Google Scholar
• Wormald MR, Dwek RA. Glycoproteins: glycan presentation and protein-fold stability. Structure. 1999;7(7):R155–R160. doi: 10.1016/s0969-2126(99)80095-1.
   PubMed Web of Science ®Google Scholar
• Kim CH. N-Glycan and O-Glycan Glycosylation in Eukaryotes. In: Kim CH, editor. The Ganglioside Biochemistry. Singapore: Springer Press; 2020. p. 15–31.
   Google Scholar
• Apweiler R, Hermjakob H, Sharon N. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim Biophys Acta. 1999;1473(1):4–8. doi: 10.1016/s0304-4165(99)00165-8.
   PubMed Web of Science ®Google Scholar
• Péanne R, de Lonlay P, Foulquier F, et al. Congenital disorders of glycosylation (CDG): Quo vadis? Eur J Med Genet. 2018;61(11):643–663. doi: 10.1016/j.ejmg.2017.10.012.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Westhrin M, Bondt A, et al. Serum protein N-glycosylation changes in multiple myeloma. Biochim Biophys Acta Gen Subj. 2019;1863(5):960–970. doi: 10.1016/j.bbagen.2019.03.001.
   PubMed Web of Science ®Google Scholar
• Lauc G, Huffman JE, Pučić M, et al. Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers. PLoS Genet. 2013;9(1):e1003225), doi: 10.1371/journal.pgen.1003225.
   PubMed Web of Science ®Google Scholar
• Huang HW, Chen CH, Lin CH, et al. B-cell maturation antigen is modified by a single N-glycan chain that modulates ligand binding and surface retention. Proc Natl Acad Sci USA. 2013;110(27):10928–10933. doi: 10.1073/pnas.1309417110.
   PubMed Web of Science ®Google Scholar
• Mittermayr S, Lê GN, Clarke C, et al. Polyclonal Immunoglobulin G N-Glycosylation in the Pathogenesis of Plasma Cell Disorders. J Proteome Res. 2017;16(2):748–762. doi: 10.1021/acs.jproteome.6b00768.
   PubMed Web of Science ®Google Scholar